Advancing gastric cancer precision medicine with novel genomic screens† is a research paper published in The Journal of Pathology (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P30CA093373
National Cancer Institute
Grant: R01CA223978
National Cancer Institute
Grant: R21CA199631
National Cancer Institute
Grant: U54CA233306
National Cancer Institute
Grant: U54CA233306‐1S2
NCI NIH HHS
Grant: U54CA233306-1S2
Fields of Study
MeSH Terms
Keywords